mRNA Therapeutics: To The Liver, And Beyond!
Source: Precision NanoSystems
In addition to an introduction to our guests, Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D., this segment from the Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, features Dr. VanCott addressing progress on targets beyond the liver.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Precision NanoSystems
This website uses cookies to ensure you get the best experience on our website. Learn more